At CMC, we leverage our vast experience to provide custom manufacturing solutions for biomolecule therapeutics. Our team of skilled scientists utilizes state-of-the-cutting-edge technology and rigorous quality control measures to ensure the highest standards for your necessary research or commerc

Bachem has shocked the pharmaceutical industry with its massive $2.3 billion acquisition of AmWiner, marking one of the largest deals in the peptide therapeutics sector this year. This strategic takeover signals Bachem's ambitious plans to dominate the growing market for peptide-based medications